Essential Concepts & Key Facts
High-yield conceptual summaries for competitive exams and rapid revision.
- An antibody, or immunoglobulin (Ig), is a specialized Y-shaped glycoprotein produced by activated B lymphocytes (plasma cells) in response to foreign antigens.
- Antibodies form the primary functional component of humoral adaptive immunity, providing targeted systemic defense against pathogens and foreign toxins.
- The basic monomeric antibody structure consists of four polypeptide chains: two identical heavy (H) chains and two identical light (L) chains joined by disulfide bonds.
- The antibody molecule divides into two functional regions: the Fab (fragment antigen-binding) arms and the Fc (fragment crystallizable) stem.
- The variable domains at the amino-terminal tips of the Fab arms contain complementary determining regions (CDRs) that bind specifically to an antigen's epitope.
- The constant Fc region binds to surface Fc receptors on immune effector cells (macrophages, neutrophils, natural killer cells) and initiates complement activation.
- Humans produce five distinct classes of immunoglobulins based on their heavy chain structure: IgG (gamma), IgM (mu), IgA (alpha), IgE (epsilon), and IgD (delta).
- IgG is the most abundant immunoglobulin in blood serum (accounting for approximately 75%–80% of circulating antibodies) and is the only class capable of crossing the placenta to confer passive immunity to the fetus.
- IgM is the largest antibody class, structured as a pentamer linked by a J-chain, and is the first immunoglobulin isotype produced during an initial primary immune response.
- IgA functions as a dimer in mucosal secretions (saliva, tears, colostrum breast milk, respiratory and intestinal fluids), protecting mucosal entry portals from microbial invasion.
- IgE binds with high affinity to Fc receptors on mast cells and basophils, mediating allergic responses and defending against parasitic helminth infections.
- IgD is expressed primarily as a membrane-bound monomeric receptor on the surface of naive B lymphocytes, participating in B-cell maturation and activation.
- Neutralization occurs when antibodies physically block viral surface proteins or bacterial toxins, rendering them incapable of attaching to host cell receptors.
- Opsonization involves antibodies coating pathogens to facilitate efficient recognition and phagocytosis by macrophages and neutrophils.
- Agglutination occurs when multivalent antibodies cross-link multiple cellular pathogens into macroscopic clumps, immobilizing them for clearance.
- Antibodies activate the classical complement pathway when C1q binds to antigen-bound IgG or IgM, resulting in the assembly of the membrane attack complex (MAC) that lyses target cells.
- Antibody-dependent cellular cytotoxicity (ADCC) occurs when natural killer (NK) cells recognize antibody-coated infected host cells via Fc receptors and release cytotoxic perforins and granzymes.
- Immense antibody diversity (exceeding 10^11 unique specificities) is generated by somatic V(D)J genetic recombination, discovered by Susumu Tonegawa who received the 1987 Nobel Prize in Medicine.
- Following an infection or vaccination, memory B cells persist for decades, enabling rapid, high-affinity IgG production upon subsequent pathogen exposure.
- Monoclonal antibodies, developed via hybridoma technology by Georges Köhler and César Milstein in 1975, are widely used as targeted therapies for cancers and autoimmune diseases.
Related Knowledge Topics to Discover
Looking for more specific GK questions?
Search across all 0 What Is an Antibody and How Does It Protect the Body? questions or browse 52,789+ verified questions across 65 domains.